tropicamide has been researched along with p-hydroxyamphetamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charap, A; Cheetham, JK; Frank, J; Larkin, KM | 1 |
| Applebaum, M; Jaanus, SD | 1 |
| Molinari, JF | 1 |
| Bartlett, JD; Semes, LP | 1 |
| Appel, S; Appleman, W; Cooper, J; Feldman, JM; Horn, D; Jaanus, SD | 1 |
| Bartlett, JD; Corliss, D; McDougall, BW; Mitten, L; Zeise, MM | 1 |
| Gaynes, BI | 1 |
| Anicho, UM; Cooper, J; Dignam, K; Feldman, J; Jaanus, SD | 1 |
3 trial(s) available for tropicamide and p-hydroxyamphetamine
| Article | Year |
|---|---|
Ideal concentration of tropicamide with hydroxyamphetamine 1% for routine pupillary dilation.
Topics: Accommodation, Ocular; Adult; Amphetamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Light; Male; p-Hydroxyamphetamine; Pupil; Pyridines; Random Allocation; Time Factors; Tropicamide | 1989 |
Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
Topics: Accommodation, Ocular; Adult; Cross-Over Studies; Double-Blind Method; Drug Combinations; Eye Color; Female; Humans; Male; Mydriatics; Ophthalmic Solutions; p-Hydroxyamphetamine; Phenylephrine; Prospective Studies; Pupil; Tropicamide; Visual Acuity | 1996 |
The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides.
Topics: Accommodation, Ocular; Adolescent; Adrenergic alpha-Antagonists; Adult; Drug Therapy, Combination; Eye Color; Female; Glare; Humans; Iris; Male; Mydriatics; Ophthalmic Solutions; Ophthalmoscopy; p-Hydroxyamphetamine; Piperazines; Pupil; Triazoles; Tropicamide; Visual Acuity | 1999 |
5 other study(ies) available for tropicamide and p-hydroxyamphetamine
| Article | Year |
|---|---|
Use of diagnostic pharmaceutical agents and incidence of adverse effects.
Topics: Adolescent; Adult; Aged; California; Child; Child, Preschool; Chlorobutanol; Cyclopentolate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Edetic Acid; Eye; Female; Fluoresceins; Humans; Infant; Male; Middle Aged; Optometry; p-Hydroxyamphetamine; Phenylephrine; Povidone; Procaine; Propoxycaine; Registries; Tropicamide | 1983 |
A clinical comparison of mydriatics.
Topics: Adult; Drug Administration Schedule; Female; Humans; Male; Mydriatics; Ophthalmoscopy; p-Hydroxyamphetamine; Pupil; Tropicamide | 1983 |
Mydriatic effectiveness of hydroxyamphetamine.
Topics: Adult; Amphetamines; Drug Interactions; Female; Humans; Male; Mydriatics; p-Hydroxyamphetamine; Phenylephrine; Random Allocation; Reflex, Pupillary; Tropicamide | 1982 |
Pupillary dilation and funduscopy with 1.0% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) versus tropicamide (0.5 or 1.0%) as a function of iris and skin pigmentation, and age.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Child, Preschool; Drug Combinations; Eye Color; Female; Fundus Oculi; Humans; Male; Middle Aged; Mydriatics; Ophthalmoscopy; p-Hydroxyamphetamine; Pupil; Skin Pigmentation; Tropicamide | 1996 |
Monitoring drug safety; cardiac events in routine mydriasis.
Topics: Cardiovascular Diseases; Drug Combinations; Drug Monitoring; Eye Diseases; Heart; Humans; Mydriatics; p-Hydroxyamphetamine; Pupil; Safety; Tropicamide | 1998 |